Read articles from North America

September 24, 2026 by substack.com

Knowledge is power in tobacco harm reduction because it gives smokers something more useful than fear. Understanding combustion, nicotine, relative risk and switching can change the choices people believe are available to them. Poor information keeps cigarettes protected by confusion, while clear information helps adults see a route away from the most harmful product. Public health should not be afraid of informed consumers; it should depend on them.

September 24, 2026 by c2cjournal.ca

Zero tolerance sounds clean until it meets real life. People do not stop wanting nicotine because policy declares the end of nicotine; they move towards whatever remains available, affordable and believable. That can mean illicit markets, continued smoking or mistrust of public health advice that refuses to distinguish between risk levels. A strategy built on eliminating nicotine may backfire unless it first deals honestly with why safer alternatives exist.

September 24, 2026 by c2cjournal.ca

Zero tolerance sounds clean until it meets real life. People do not stop wanting nicotine because policy declares the end of nicotine; they move towards whatever remains available, affordable and believable. That can mean illicit markets, continued smoking or mistrust of public health advice that refuses to distinguish between risk levels. A strategy built on eliminating nicotine may backfire unless it first deals honestly with why safer alternatives exist.

September 23, 2026 by substack.com

Knowledge is power in tobacco harm reduction because it gives smokers something more useful than fear. Understanding combustion, nicotine, relative risk and switching can change the choices people believe are available to them. Poor information keeps cigarettes protected by confusion, while clear information helps adults see a route away from the most harmful product. Public health should not be afraid of informed consumers; it should depend on them.

September 23, 2026 by 2firsts.com

A nicotine substitute entering the market before key human evidence is available should make regulators ask better questions, not reach for easy assumptions. New molecules such as 6-methyl nicotine may sit outside familiar tobacco and nicotine frameworks, but that does not make them automatically safer, riskier or irrelevant. The priority should be transparent testing, pharmacology, exposure data and real-world monitoring before public health claims are made. Innovation can support harm reduction only when the evidence keeps pace with the product.

September 23, 2026 by 2firsts.com

A nicotine substitute entering the market before key human evidence is available should make regulators ask better questions, not reach for easy assumptions. New molecules such as 6-methyl nicotine may sit outside familiar tobacco and nicotine frameworks, but that does not make them automatically safer, riskier or irrelevant. The priority should be transparent testing, pharmacology, exposure data and real-world monitoring before public health claims are made. Innovation can support harm reduction only when the evidence keeps pace with the product.

September 23, 2026 by consideratepouchers.org

Smoke-free alternatives are being pulled into a policy fight that often forgets why they matter in the first place. The issue is not whether nicotine should be celebrated; it is whether adults who smoke are allowed realistic ways to reduce their exposure to burning tobacco. A war on pouches, vapes and other non-combustible products can quickly become a defence of the cigarette by default. Harm reduction asks a simpler question: does the policy make the most dangerous choice easier or harder to leave behind?

September 22, 2026 by reason.org

Half a billion dollars to fight a collapsing trend deserves scrutiny. Youth vaping has fallen sharply, yet lawmakers are still treating it as an expanding emergency while adult smoking remains the bigger driver of preventable disease. Resources should follow the scale of harm, not the politics of alarm. Serious nicotine policy would protect young people without using outdated crisis language to justify measures that may also make quitting harder for adults.

September 22, 2026 by thejournal.ie

The phrase “vaping is worse than smoking” does more than misstate the evidence — it changes behaviour. A smoker who believes that message may see little reason to switch, even though cigarettes remain the far more harmful product. Good fact-checking restores the missing hierarchy: vaping is not harmless, but it is not smoking. Clear risk communication can be the difference between staying with combustion and taking a less harmful route away from it.

September 21, 2026 by regulatorwatch.com

Nicotine pouch testing should be driven by science, not suspicion by category. Better data on ingredients, emissions, exposure and product performance can help regulators distinguish between responsible smoke-free products and those that fail basic standards. That matters because credible harm reduction depends on transparency as much as access. The stronger the testing framework, the harder it becomes to dismiss pouches with fear — or to defend products that do not meet the evidence.